These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

These 2 Growth Stocks Have Fallen Out of Grace. Are They Buys?

In the past two years, biotech companies Moderna (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) rose to fame thanks to their successful attempts to develop vaccines for COVID-19 and help us end the outbreak. The pandemic isn't over yet, but Moderna and Novavax have given up substantial chunks of their value in the past year. Where does that leave Moderna and Novavax?